Stephan Moll, MD
Disclosures: Paid consultant-Pfizer, Inc.-|Honoraria-Stago Diagnostics- - 05/13/2021
Faculty Biographic Sketch

Stephan Moll, MD

 

 

Stephan Moll, MD, received his medical degree from Freiburg University, Germany, including a one year of clinical training in London (Hammersmith Hospital and Institute of Neurology at Queens Square), and performed a pathology residency at the Institute of Pathology, University of Aachen, Germany. He completed an internship and residency in Internal Medicine and a Hematology-Oncology fellowship at Duke University Medical Center, North Carolina, and a one-year Clinical Coagulation fellowship at the University of North Carolina (UNC), Chapel Hill. Dr Moll has been a faculty member at the University of North Carolina in the Department of Medicine and the Division of Hematology-Oncology since 1999, now at the rank of full professor.

 

His clinical interest is coagulation and classical hematology, with a particular focus on thrombosis and anticoagulation. Dr Moll’s research interests include clinical trials on new anticoagulants and better use of established anticoagulants. He takes a special interest in clinical-medical education of healthcare professionals, patients and the public, and is a cofounder of the UNC Blood Clot Education Program Clot Connect, at www.clotconnect.org. His four main professional goals for the next 5-10 years are to (1) enhance national and local patient and health care provider education activities on venous thromboembolism, (2) continue to build an “Athletes and Blood Clot Program”, (3) support trainees in their career development in the field of coagulation/hematology, (4) assist in identifying the etiology and best treatment of Livedoid Vasculopathy.